To compare the efficacy of fingolimod and natalizumab in preventing regional grey matter (GM) and white matter (WM) atrophy in relapsing-remitting multiple sclerosis (RRMS) over 2 years.
Two-year regional grey and white matter volume changes with natalizumab and fingolimod / Preziosa, Paolo; Rocca, Maria A; Pagani, Elisabetta; Storelli, Loredana; Rodegher, Mariaemma; Moiola, Lucia; Filippi, Massimo. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 91:5(2020), pp. 493-502. [10.1136/jnnp-2019-322439]
Two-year regional grey and white matter volume changes with natalizumab and fingolimod
Preziosa, Paolo;Rocca, Maria A;Filippi, Massimo
2020-01-01
Abstract
To compare the efficacy of fingolimod and natalizumab in preventing regional grey matter (GM) and white matter (WM) atrophy in relapsing-remitting multiple sclerosis (RRMS) over 2 years.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
